These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3063850)

  • 1. [Clinical trials of flomoxef in patients with chronic respiratory tract infections].
    Ida S; Nishioka K; Takishima T
    Jpn J Antibiot; 1988 May; 41(5):571-6. PubMed ID: 3063850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study of flomoxef in the pediatric field].
    Sato H; Narita A; Nakazawa S; Suzuki H; Mastumoto K; Nakanishi Y; Nakazawa S; Niino K; Nakada Y
    Jpn J Antibiot; 1987 Aug; 40(8):1349-63. PubMed ID: 3430712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluations of flomoxef in respiratory tract infections].
    Mikasa K; Sawaki M; Ako H; Narita N
    Jpn J Antibiot; 1987 Oct; 40(10):1794-8. PubMed ID: 3444019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on flomoxef in respiratory tract infections].
    Kanegae H; Yamada H; Yamaguchi T; Kuroki S; Katoh O
    Jpn J Antibiot; 1987 Oct; 40(10):1803-8. PubMed ID: 3444021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on flomoxef in respiratory infection].
    Yoshida M; Miyahara S; Aritomi T; Seki M; Ishibashi M
    Jpn J Antibiot; 1987 Oct; 40(10):1799-802. PubMed ID: 3444020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and clinical studies of flomoxef].
    Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H
    Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)].
    Shimada K; Oguri T; Igari J; Ikemoto H; Mori T; Kitamura N; Nakano K; Suzuki Y; Yokouchi H; Karasawa Y; Terai T; Yamamoto M; Nakata K; Nakatani T; Inoue H; Nakadate T; Inagawa H; Suwabe A; Obata R; Kudo K; Kobayashi N; Ohno I; Okada S; Hayashi K; Kinoshita T; Konosaki H; Arakawa M; Gejyo F; Kobayashi H; Goto H; Igarashi K; Kawai S; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Suga M; Hirakata Y; Aoki S; Matsuda J; Tosaka M; Nasu M; Nagai H; Kohno S; Tomono K; Miyazaki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2003 Oct; 56(5):365-95. PubMed ID: 14692377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on flomoxef against respiratory infections in the aged].
    Tanimoto H; Chonabayashi N; Nakamori Y; Nakatani T; Yoshimura K; Noguchi M; Nakata K
    Jpn J Antibiot; 1987 Oct; 40(10):1767-73. PubMed ID: 3444017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of clinical effect of flomoxef].
    Noguchi Y; Yoneda S; Fukuda Y; Nakata M; Honma T; Yoshida K
    Jpn J Antibiot; 1987 Oct; 40(10):1763-6. PubMed ID: 3444016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological and clinical studies of flomoxef in the pediatric field].
    Kuroki S; Haruta T; Tsutsui T; Yamamoto H; Okura K; Yamaoka K; Yoshioka N; Kobayashi Y
    Jpn J Antibiot; 1987 Aug; 40(8):1447-61. PubMed ID: 3430720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.